Rhythm Pharmaceuticals Stock
Rhythm Pharmaceuticals Stock
Rhythm Pharmaceuticals took a tumble today and lost -€2.500 (-3.130%).
The stock is an absolute favorite of our community with 40 Buy predictions and no Sell predictions.
With a target price of 103 € there is a positive potential of 32.9% for Rhythm Pharmaceuticals compared to the current price of 77.5 €.
Our community identified positive and negative aspects for Rhythm Pharmaceuticals stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Rhythm Pharmaceuticals stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | -3.130% | -3.727% | -5.488% | 68.607% | -17.112% | 342.857% | 265.566% |
| Heron Therapeutics Inc. | -5.000% | -7.083% | -20.452% | -64.977% | -30.521% | -65.330% | -94.528% |
| Evolus Inc | 0.000% | -8.936% | 18.889% | -63.729% | -21.468% | -45.823% | -56.442% |
| Sangamo Therapeutics Inc. | -5.730% | 2.026% | 1.590% | -62.380% | -5.003% | -84.119% | -96.551% |
Comments
Rhythm Pharmaceuticals (RYTM) had its price target raised by Wells Fargo & Company from $136.00 to $143.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $125.00 to $110.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat